Incidence Trends of Primary Cutaneous T-Cell Lymphoma in the US From 2000 to 2018-Reference-Cited by-同舟云学术

Incidence Trends of Primary Cutaneous T-Cell Lymphoma in the US From 2000 to 2018

Published:2022-11-01 Issue:11 Volume:8 Page:1690
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Cai Zhuo Ran¹,Chen Michael L.²,Weinstock Martin A.³⁴⁵,Kim Youn H.²⁶,Novoa Roberto A.²⁷,Linos Eleni²⁸

Affiliation:

1. Program for Clinical Research and Technology, Stanford University, Stanford, California

2. Department of Dermatology, Stanford University School of Medicine, Stanford, California

3. Center for Dermatoepidemiology, Providence Veterans Affairs Medical Center, Providence, Rhode Island

4. Department of Dermatology, Brown University, Providence, Rhode Island

5. Department of Epidemiology, Brown University, Providence, Rhode Island

6. Department of Medicine (Oncology), Stanford University School of Medicine, Stanford, California

7. Department of Pathology, Stanford University School of Medicine, Stanford, California

8. Stanford Cancer Institute, School of Medicine, Stanford, California

Abstract

Using SEER database data, this cohort study analyzed cutaneous T-cell lymphoma incidence by tumor subtype, sex, age, race and ethnicity, socioeconomic status, and geography.

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2795982/jamaoncology_cai_2022_ld_220019_1668658028.151.pdf

Reference6 articles.

1. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups.;Yost;Cancer Causes Control,2001

2. Changing incidence trends of cutaneous T-cell lymphoma.;Korgavkar;JAMA Dermatol,2013

3. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.;Ghazawi;Cancer,2017

4. Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry.;Dobos;Br J Dermatol,2021

5. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.;Criscione;Arch Dermatol,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to Wu et al's US SEER analysis of sepsis in Black patients with CTCL;Journal of the American Academy of Dermatology;2024-02

2. Real-World Treatment Patterns and Clinical Outcomes With Brentuximab Vedotin or Other Standard Therapies in Patients With Previously Treated Cutaneous T-Cell Lymphoma in the United States;Clinical Lymphoma Myeloma and Leukemia;2024-02

3. Racial Disparities in Mycosis Fungoides/Sézary Syndrome–A Single-Center Observational Study of 292 Patients;Clinical Lymphoma Myeloma and Leukemia;2024-01

4. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023;European Journal of Cancer;2023-12

5. Cutaneous T cell lymphoma atlas reveals malignant Th2 cells supported by a B cell-rich microenvironment;2023-11-07